Therapeutically reeducating macrophages to treat GBM
- PMID: 24100977
- DOI: 10.1038/nm.3355
Therapeutically reeducating macrophages to treat GBM
Abstract
Glioblastoma multiforme (GBM) is the most common type of aggressive malignant brain cancer. The current lack of successful therapeutics means that this disease has a dismal prognosis. However, a new study in mice offers hope for patients with GBM by demonstrating the efficacy of a novel drug that targets GBM-associated macrophages (pages 1264–1272).
Comment on
-
CSF-1R inhibition alters macrophage polarization and blocks glioma progression.Nat Med. 2013 Oct;19(10):1264-72. doi: 10.1038/nm.3337. Epub 2013 Sep 22. Nat Med. 2013. PMID: 24056773 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
